SARS-CoV-2 seropositivity and subsequent infection risk in healthy young adults: a prospective cohort study

0 views • Oct 30, 2021
0
Save
Cite
Share

Author(s)

Author Name

Andrew G Letizia

Published 1 Project

Infectious Diseases

Yongchao Ge

Published 1 Project

Infectious Diseases

Sindhu Vangeti

Published 1 Project

Infectious Diseases

Carl Goforth

Published 1 Project

Infectious Diseases

Dawn L Weir

Published 1 Project

Infectious Diseases

Natalia A Kuzmina

Published 1 Project

Infectious Diseases

Hua Wei Chen

Published 1 Project

Infectious Diseases

Dan Ewing

Published 1 Project

Infectious Diseases

Alessandra Soares-Schanoski

Published 1 Project

Infectious Diseases

Mary-Catherine George

Published 1 Project

Infectious Diseases

William D Graham

Published 1 Project

Infectious Diseases

Franca Jones

Published 1 Project

Infectious Diseases

Preeti Bharaj

Published 1 Project

Infectious Diseases

Rhonda A Lizewski

Published 1 Project

Infectious Diseases

Stephen A Lizewski

Published 1 Project

Infectious Diseases

Jan Marayag

Published 1 Project

Infectious Diseases

Nada Marjanovic,

Published 1 Project

Infectious Diseases

Clare Miller

Published 1 Project

Infectious Diseases

Sagie Mofsowitz

Published 1 Project

Infectious Diseases

Venugopalan D. Nair

Published 1 Project

Infectious Diseases

Edgar Nunez

Published 1 Project

Infectious Diseases

Danielle M Parent

Published 1 Project

Infectious Diseases

Chad K Porter

Published 1 Project

Infectious Diseases

Ernesto Santa Ana

Published 1 Project

Infectious Diseases

Megan Schilling

Published 1 Project

Infectious Diseases

Victor Sugiharto

Published 1 Project

Infectious Diseases

Michael S Termini

Published 1 Project

Infectious Diseases

Peifang Sun

Published 1 Project

Infectious Diseases

Uploader

Florian Krammer

Alexander Bukreyev

Published 2 Projects

Microbiology Infectious Diseases

Ramos Irene

Published 1 Project

Infectious Diseases

Stuart C. Sealfon

Published 1 Project

Infectious Diseases

Add New Author

Background: The risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) subsequent infection among seropositive young adults was studied prospectively. Methods: The study population comprised 3,249 predominantly male, 18-20-year-old Marine recruits. Upon arrival at a Marine-supervised two-week quarantine, participants were assessed for baseline SARS-CoV-2 IgG seropositivity, defined as a 1:150 dilution or greater on receptor binding domain and full-length spike protein enzyme-linked immunosorbent (ELISA) assays. SARS-CoV-2 infection was assessed by PCR at initiation, middle and end of the quarantine. After appropriate exclusions, including participants with a positive PCR during quarantine, we performed three biweekly PCR tests in both seropositive and in seronegative groups once recruits left quarantine and entered basic training and baseline neutralizing antibody titers on all subsequently infected seropositive and selected seropositive uninfected participants. Findings: Among 189 seropositive participants, 19 (10.1%) had at least one positive PCR test for SARS-CoV-2 during the six-week follow-up (1.1 cases per person-year). In contrast, 1,079 (48.0%) of the 2,247 seronegative participants tested positive (6.2 cases per person-year). The incidence rate ratio was 0.18 (95% CI 0.11-0.28, p<0.00001). Among seropositive recruits, infection was associated with lower baseline full-length spike protein IgG titers (p<0.0001). Compared with seronegative recruits, seropositive recruits had about 10-fold lower viral loads (ORF1ab gene, p<0.005), and trended towards shorter duration of PCR positivity (p=0.18) and more frequent asymptomatic infections (p=0.13). Among seropositive participants, baseline neutralizing titers were detected in 45 of 54 (83.3%) uninfected and in 6 of 19 (31.6%) infected participants during the 6 weeks of observation (ID50 difference p<.0001). Interpretation: Seropositive young adults had about one-fifth the risk of subsequent infection compared with seronegative individuals. Although antibodies induced by initial infection are largely protective, they do not guarantee effective SARS-CoV-2 neutralization activity or immunity against subsequent infection. These findings may be relevant for optimization of mass vaccination strategies.

Infectious Diseases
Infectious Diseases 62 Projects